ZMYM3 Activators
ZMYM3 Activators refers to a class of chemical compounds that have gained attention within the realm of molecular biology and cellular research. These activators are characterized by their ability to modulate the activity of the ZMYM3 protein, also known as Zinc Finger MYM-type Containing 3. ZMYM3 is a zinc finger protein, a type of transcription factor that plays a crucial role in gene regulation and chromatin remodeling. In particular, it is known to interact with various transcriptional co-regulators and epigenetic modifiers, which makes it a central player in the intricate orchestration of gene expression. The activation of ZMYM3 is critical for a range of cellular processes, and ZMYM3 activators are designed to facilitate this activation by specifically binding to the ZMYM3 protein.
The molecular mechanisms by which ZMYM3 activators operate are complex and multifaceted. They are designed to enhance the interaction between ZMYM3 and its associated co-regulators, thereby promoting the recruitment of transcriptional machinery and the modification of chromatin structure to facilitate gene expression. These activators often have a high degree of selectivity for ZMYM3, minimizing potential off-target effects. The research into ZMYM3 activators holds promise for a deeper understanding of gene regulation and its implications in various cellular processes. This chemical class is at the forefront of ongoing investigations to elucidate the specific pathways and molecular interactions influenced by ZMYM3 activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A Histone Deacetylase (HDAC) inhibitor with the capacity to increase chromatin remodeling, potentially leading to the activation of ZMYM3. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
An HDAC activator that can activate ZMYM3 by modifying histone acetylation. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
A DNA-binding compound that interacts with DNA, potentially affecting gene regulation, including the activation of ZMYM3. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can activate ZMYM3 by modulating protein degradation processes. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An NF-κB inhibitor that targets the NF-κB signaling pathway, which intersects with ZMYM3-related pathways, potentially leading to the activation of ZMYM3. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
A Wnt pathway modulator that can increase Wnt signaling, potentially impacting the transcriptional regulation of ZMYM3, leading to activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K/AKT/mTOR pathway inhibitor that can affect signaling pathways involved in gene regulation, potentially leading to the activation of ZMYM3. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A Notch pathway modulator that influences the Notch signaling pathway, which intersects with ZMYM3-related pathways, potentially leading to the activation of ZMYM3. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
An HDAC activator increasing histone acetylation and gene expression, which can impact ZMYM3 activation. | ||||||